Abstract:Abstract Despite evidence of clear benefit, genetic testing of pediatric oncology patients for germline variants remains rare due to a variety of factors, including insurance/financial barriers, limited knowledge about genetic testing, and competing interests for time and resources. Limited access to genetic testing, pre-test counseling and multidisciplinary care have been shown to disproportionately affect patients with limited resources. This represents a critical unmet need in pediatric oncology. Genetic testing station (GTS) is a pre-test counseling video tool that reviews what genetic testing is, why it might be indicated, and explains potential results. Similar video tools have been successfully used in other settings to increase rates of genetic testing, but there are no published reports on the effectiveness of a video education intervention to increase genetic testing in pediatric oncology patients. To test the effectiveness of GTS on genetic testing knowledge and feelings about genetic testing compared to in-person counseling, we use 5 previously validated tools pre- and post-intervention. The initial surveys measure genetic testing knowledge, decisional conflict, healthy literacy, evaluation of GTS and demographics. If participants complete genetic testing, we use the MICRA to assess the impact on their cancer risk assessment. Our GTS arm is recruited from UCLA Pediatric Sarcoma patients, and the in-person counseling arm is recruited from the UCLA Cancer Predisposition clinic. We have recruited 28 participants in the GTS arm and seven in the in-person counseling arm, of which 10 are patients over 18 years old, two are patients between 12-17 years old, and 23 are parents. In our GTS arm, there are 20 female and eight male participants. A majority identify as white or Latino. For the in-person counseling arm, there are four male and three female participants who identify as white, Middle Eastern, or Latino. A similar percentage score with high health literacy, 68% in the GTS arm and 71% for the in-person counseling arm. The majority of patients have no decisional conflict pre- or post-intervention for the GTS group, while the in-person counseling arm shows high initial decision conflict that is fully resolved with counseling. There is a statistically significant increase in genetic testing knowledge for five out of 10 questions comparing pre- and post-GTS. For GTS participants who have completed genetic testing and the MICRA, there is overall low distress and uncertainty, but higher scores for parents than adult or minor patients. In conclusion, there has been high interest in germline genetic testing in pediatric oncology patients with all families deciding to pursue genetic testing after viewing GTS. GTS is an effective tool in increasing genetic testing knowledge in participants. Therefore, GTS is a promising approach to increase access to genetic testing, while providing adequate pre-test counseling and no decisional conflict. Citation Format: Camille Hamilton, Mariana Niell Swiller, Franceska Bhansali, Alyssa Hoover, Stephanie Bottomley, Marisa Lewis, Bianca Russell, Julian A. Martinez, Beth Karlan, Noah Federman, Vivian Y. Chang. Genetic testing station increases access to germline genetic testing [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 6375.

Familial communication and cascade testing following elective genomic testing

Factors Impacting Intent to Share Multigenic Cancer Testing Results in a Community Hospital Setting

Actionability and familial uptake following opportunistic genomic screening in a pediatric cancer cohort

A Genomic Counseling Model for Population-Based Sequencing: A Pre-Post Intervention Study

Lessons Learned from Expanded Reproductive Carrier Screening in Self‐reported Ashkenazi, Sephardi, and Mizrahi Jewish Patients

Acceptability and Usability of the Family Gene Toolkit for Swiss and Korean Families Harboring BRCA1/BRAC2 Pathogenic Variants: A Web-Based Platform for Cascade Genetic Testing

Genetic Counseling, Testing, and Family Communication Into Survivorship After Diagnosis of Breast Cancer

Feasibility and Clinical Utility of Reporting Hereditary Cancer Predisposition Pathogenic Variants Identified in Research Germline Sequencing: A Prospective Interventional Study

Use of a chatbot to increase uptake of cascade genetic testing

Abstract 6375: Genetic testing station increases access to germline genetic testing

Extended Family Outreach in Hereditary Cancer Using Web-Based Genealogy, Direct-to-Consumer Ancestry Genetics, and Social Media: Mixed Methods Process Evaluation of the ConnectMyVariant Intervention

Family health beliefs and cascade genetic testing in Asian families with hereditary cancer risk: "Okay, now what?"

Barricades to aiding cascading: Patient-reported barriers to uptake in the context of clinician-facilitated cascade testing for hereditary cancer syndromes.

Timely targeted testing for hereditary cancer syndromes - Importance of clinician-facilitated cascade testing in the first year post-diagnosis

Primary Care Implementation of Genomic Population Health Screening Using a Large Gene Sequencing Panel

Expanded carrier screening for inherited genetic disease using exome and genome sequencing

Innovative Implementation Strategies for Familial Hypercholesterolemia Cascade Testing: The Impact of Genetic Counseling

The NYCKidSeq randomized controlled trial: Impact of GUÍA digitally enhanced genetic counseling in racially and ethnically diverse families

A Randomized Trial of Two Remote Healthcare Delivery Models on the Uptake of Genetic Testing and Impact on Patient-Reported Psychological Outcomes in Families With Pancreatic Cancer: The Genetic Education, Risk Assessment, and Testing (GENERATE) Study

Implementing a genetic testing station in a safety net setting for equitable genetic testing and counseling.

Cascade genetic testing: an underutilized pathway to equitable cancer care?